Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Neville, Hoffman"'
Autor:
Ernest T. Hawk, Thomas Sylwestrowicz, Bruce Salzberg, John R. Saltzman, Ronald E. Pruitt, Finlay Macrae, Neville Hoffman, T. Raymond Foley, Thomas Dewar, Daniel C. Chung, John Burn, Neal T. Collins, Donya Bagheri, Asad Umar, Rebecca B. Rosenstein, Jie Tang, KyungMann Kim, Aurora Breazna, Mark Redston, Ann G. Zauber, Craig J. Eagle, Monica M. Bertagnolli
Perspective on this Article from Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3113a9c54a3b7bfd7fdaece3096f1cd6
https://doi.org/10.1158/1940-6207.22523892.v1
https://doi.org/10.1158/1940-6207.22523892.v1
Autor:
Ernest T. Hawk, Thomas Sylwestrowicz, Bruce Salzberg, John R. Saltzman, Ronald E. Pruitt, Finlay Macrae, Neville Hoffman, T. Raymond Foley, Thomas Dewar, Daniel C. Chung, John Burn, Neal T. Collins, Donya Bagheri, Asad Umar, Rebecca B. Rosenstein, Jie Tang, KyungMann Kim, Aurora Breazna, Mark Redston, Ann G. Zauber, Craig J. Eagle, Monica M. Bertagnolli
Supplementary Information from Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a7ca1e0fef4a828ff27e5e81d4b65d8
https://doi.org/10.1158/1940-6207.22523889.v1
https://doi.org/10.1158/1940-6207.22523889.v1
Autor:
Monica M, Bertagnolli, Craig J, Eagle, Ann G, Zauber, Mark, Redston, Aurora, Breazna, Kyungmann, Kim, Jie, Tang, Rebecca B, Rosenstein, Asad, Umar, Donya, Bagheri, Neal T, Collins, John, Burn, Daniel C, Chung, Thomas, Dewar, T Raymond, Foley, Neville, Hoffman, Finlay, Macrae, Ronald E, Pruitt, John R, Saltzman, Bruce, Salzberg, Thomas, Sylwestrowicz, Ernest T, Hawk, S J, Van Zantan
Publikováno v:
Cancer prevention research (Philadelphia, Pa.). 2(4)
The Adenoma Prevention with Celecoxib Trial examined the efficacy and safety of the cyclooxygenase (Cox)-2 inhibitor, celecoxib, for sporadic colorectal adenoma prevention in patients at high risk for colorectal cancer. The trial randomized 2,035 sub